ARTICLE | Clinical News
Nebivolol regulatory update
June 6, 2005 7:00 AM UTC
MYL received an approvable letter from FDA for nebivolol to treat hypertension. Approval is contingent on providing additional preclinical data and finalizing the label. MYL is conducting a preclinica...